Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new program.

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

The new recommendation will significantly expand access to Wegovy on the England's NHS.

Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.